(Q55257821)

29 June 2018

title

Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

4 October 2022

1 reference

ChEBI release 2020-05-28

K. Okamoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

4 October 2022

K. Harada

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

4 October 2022

S. Ikeyama

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

4 October 2022

S. Iwasa

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

4 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1517150

4 October 2022

publication date

1 July 1992

1 reference

29 June 2018

number of pages

8

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/PMC5918935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

https://europepmc.org/articles/PMC5918935?pdf=render

4 October 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1517150

Japanese Journal of Cancer Research

4 October 2022

published in

1 reference

29 June 2018

volume

83

1 reference

29 June 2018

issue

7

1 reference

29 June 2018

page(s)

761-768

1 reference

29 June 2018

A pharmacokinetic analysis program (multi) for microcomputer

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Linkage of cytotoxic agents to immunoglobulins

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Binding of apotransferrin to K562 cells: explanation of the transferrin cycle

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Receptor for transferrin may be a "target" structure for natural killer cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

An improved colorimetric assay for interleukin 2.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Tumour therapy with Vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and Vinca alkaloids.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

The use of hybrid hybridomas to target human cytotoxic T lymphocytes.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Hybrid antibodies can target sites for attack by T cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Advantages of bispecific hybridomas in one-step immunocytochemistry and immunoassays

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Evaluation of a conjugate of purified antibodies against human AFP-dextran-daunorubicin to human AFP-producing yolk sac tumor cell lines

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Preliminary trial of specific targeting therapy against malignant glioma

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Immunoconjugates containing novel maytansinoids: promising anticancer drugs

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Isolation and characterization of the transferrin receptor from human placenta

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Enzyme immunoassay of a β-adrenergic agent using β-galactosidase as label

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Production and ELISA application of bispecific monoclonal antibodies against fluorescein isothiocyanate (FITC) and horseradish peroxidase (HRP).

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5918935

Bispecific antibody-producing hybrid hybridomas selected by a fluorescence activated cell sorter

13 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1992.TB01977.X

Ansamitocin, a group of novel maytansinoid antibiotics with antitumour properties from Nocardia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1992.TB01977.X

Hybrid hybridomas and their use in immunohistochemistry

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1992.TB01977.X

Site-specific linkage of methotrexate to monoclonal antibodies using an intermediate carrier

21 January 2018

1 reference

12 December 2020

Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine tumors in vivo and on the assembly of microtubules in vitro

1 reference

12 December 2020

Selective cytotoxicity of drug-monoclonal antibody conjugates against murine bladder tumor cells

1 reference

12 December 2020

Chemical modification of ansamitocins. III. Synthesis and biological effects of 3-acyl esters of maytansinol

1 reference

12 December 2020

The effect of bispecific monoclonal antibody recognizing both hepatoma-specific membrane glycoprotein and anthracycline drugs on the metastatic growth of hepatoma AH66.

1 reference

12 December 2020

Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

1 reference

12 December 2020

Inhibition of human lymphocyte proliferation by monoclonal antibody to transferrin receptor

1 reference

12 December 2020

Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells

1 reference

12 December 2020

Bispecific antibody-producing hybrid hybridoma and its use in one-step immunoassays for human lymphotoxin

1 reference

12 December 2020

Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator

1 reference

12 December 2020

Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody

1 reference

12 December 2020

Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones

1 reference

12 December 2020

10.1111/J.1349-7006.1992.TB01977.X

Identifiers

DOI

1 reference

29 June 2018

PMC publication ID

5918935

1 reference

29 June 2018

1 reference

29 June 2018